中  文
Stock Short Name:Hybio Pharmaceutical | Stock Exchange Code:300199
OA系統網絡商學院

News

More
AAPS Annual Meeting and Exposition Nov 9-1...
2009.3.18 Professor K.C.Nicolaou visited

Company Profile

More

Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical company in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services. Our peptide finished dosage is mainly sold in the domestic market, but some of our peptide APIs have been supplied to customers all over the world. Hybio is a GMP-approved pharmaceutical company. Our GMP plant in Shenzhen is a facility occupying an area of more than 1,5000 sq.m. It has been often audited and inspected by local/national s-FDA authorities and by clients all over the world.

手机反复操作的赚钱项目 百家乐翻天粤语 三分彩走势 江苏11选5一定牛 上海天天彩选四基本走势图 腾讯分分彩免费全天精准计划 刮刮乐表情包 上海时时乐购彩平台 六肖免费中特期期公开 体彩黑龙江6+1开奖结果查询 欢乐电玩城破解版 北京麻将小游戏单机版 欧冠吧 大众麻将算法 欧冠赛程积分榜 乐趣棋牌游戏 股市权重股是什么意思